Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (29)

« Back to Publications

Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association study.

Attfield KE. et al, (2026), Lancet Neurol, 25, 482 - 491

A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosis.

Giordano A. et al, (2026), Acta Neuropathol, 151

T cells turn in Alzheimer's disease.

Skelly D. et al, (2025), Brain, 148, 3034 - 3036

A repair pathway lost in multiple sclerosis provides a new drug opportunity.

Jensen LT. et al, (2024), Nat Immunol, 25, 385 - 386

Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases.

Lippert AH. et al, (2024), Immunity, 57, 256 - 270.e10

Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations.

Barrie W. et al, (2024), Nature, 625, 321 - 328

Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors.

Jensen LT. et al, (2023), EBioMedicine, 97

Acute Inflammatory Diseases of the Central Nervous System After SARS-CoV-2 Vaccination.

Francis AG. et al, (2023), Neurol Neuroimmunol Neuroinflamm, 10

The immunology of multiple sclerosis.

Attfield KE. et al, (2022), Nat Rev Immunol, 22, 734 - 750

Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade.

Kaur G. et al, (2022), Nat Commun, 13

Identification of early neurodegenerative pathways in progressive multiple sclerosis.

Kaufmann M. et al, (2022), Nat Neurosci, 25, 944 - 955

Elevated genetic risk for multiple sclerosis originated in Steppe Pastoralist populations

Barrie W. et al, (2022)

Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis.

Kaufmann M. et al, (2021), Med, 2, 296 - 312.e8

Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient.

Wurm H. et al, (2020), Mult Scler, 26, 1261 - 1264

A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.

Faergeman SL. et al, (2020), Cell Death Dis, 11

Load More